Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.71), $0.02 worse than the analyst estimate of ($0.69). Revenue for the quarter came in at $1.18 million versus the consensus estimate of $825.56 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.